Brief: Proteomics International Laboratories Says Australian TGA Decided Not To Include PromarkerD Test In ARTG
Sept 29 (Reuters) - Proteomics International
Laboratories Ltd PIQ.AX :
* AUSTRALIAN TGA ADVISES DECISION NOT TO INCLUDE PROMARKERD
TEST
IN AUSTRALIAN REGISTER OF THERAPEUTIC GOODS
* TGA DECISION DOES NOT AFFECT CO'S ACTIVITIES IN PRIMARY
MARKETS
OF UNITED STATES AND EUROPE
* TGA DECISION NOT TO INCLUDE PROMARKERD TEST IN ARTG DUE
PRIMARILY TO CHANGE OF MANUFACTURER
Source text for Eikon: ID:nASX7bdnvR
Further company coverage: PIQ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Launches Share Purchase Plan To Raise Up To A$5 MLN
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius